The Junior Compliance specialist CEE+ (CEE countries: Bulgaria, Croatia, Chechia, Hungary, Poland, Romania, Slovakia, Slovenia and partner markets (Israel, relevant counties in the Balkan and CIS) will support the increasing scope and complexity of compliance activities driven by upcoming launches, expanding teams, and growing business operations.
Key responsibilities:
Support monitoring activities (data collection)
Support monitoring CAPAs
Support transfer of value reporting
Manage annual FMV updates
Preparation, communication and monitoring of Data Privacy Notice (DPN)
Support compliance trainings (systems)
Support with systems by being a super user (e.g. Veeva, SOOS)
Supporting Compliance Director and Senior Compliance Manager with various tasks
2-3 years of experience in compliance
2-3 years of pharma business experience
Located in one of the CEE countries
Good knowledge of regional and local Code of Practices as well as key regulations relating to broader aspects of compliance
Working knowledge of the healthcare systems in CEE country/ies
Proven track record of having undertaken compliance roles within the pharmaceutical industry
Business partnering capabilities
Strong analytical skills
Excellent written and verbal English skills
Detailed oriented, good communicator, flexible, self-assured individual
Interest in IT tools and trainings At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.
Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:
Collaborative and team-oriented environment
Making a positive impact to help patients
Opportunities for professional growth
Emphasis on work/life balance
Competitive compensation for your work
Diversity and Inclusion
Sobi is a specialty pharmaceutical company focused on improving the lives of people living with rare and orphan diseases, particularly those affecting metabolism and lipid disorders. The company specializes in the development and commercialization of treatments for conditions such as FSC (Familial Chylomicronemia Syndrome) and sTGH (Severe Triglyceridemia), with a mission centered on patient-centric care and appropriate disease identification. Sobi operates internationally with a strong emphasis on cross-regional collaboration, leveraging digital engagement, medical affairs expertise, and market access strategies to ensure timely patient diagnosis and treatment adoption. The company integrates scientific insights with commercial execution to create scalable frameworks and omnichannel engagement approaches for healthcare providers, payers, and patient organizations.
